This article needs additional citations for
verification. (August 2015) |
Keystone Nano, founded in 2005, is an American-based company based in Pennsylvania, that creates nanoscale products to diagnose and treat human disease and improve the quality of life. [1]
Keystone Nano Inc. and team has been granted the follow patents:
In January 2017, the FDA approved the investigational new drug application, NanoLiposome, to assess the product as a form of treatment for solid tumors. Phase 1 trials will take place at the University of Maryland, University of Virginia, and the Medical University of South Carolina. [4]
Keystone was approved in 2017 to begin clinical trials to assess ceramide nanoliposome for possible use in treating cancer. [5]